Jason P. Rhodes, Director: Dyne Therapeutics DYN Sell · Filed 24/02/23

Trade details

Type: Insider sale
Amount: $3,621,603.4
Shares · price: 159,542 sh · $22.70 a share
Held after: 6,352,562 sh
Stock: Dyne Therapeutics DYN
Person: Jason P. RhodesDirector
Trade date: 24/02/23
Filed: 24/02/23
Days to filing: 0 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/24~24/03/24

Jason P. Rhodes's recent trades

Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$3.5M
162,954 sh
$3.5M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2.2M
102,969 sh
$2.2M
Filed 06/30
Traded 06/29
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.7M
81,903 sh
$1.7M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.4M
64,411 sh
$1.4M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.1M
51,756 sh
$1.1M
Filed 06/30
Traded 06/29